Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
LSL Pharma Group Inc ( (TSE:LSL) ) just unveiled an update.
LSL Pharma Group Inc. has announced the acquisition of Juno OTC Inc., a Toronto-based subsidiary of Juno Pharmaceuticals LP, for $5 million, aiming to expand its business portfolio and revenue streams in the thriving OTC consumer healthcare market. As part of the acquisition, LSL Pharma gains access to over 40 Health Canada approved OTC drugs, natural health products, and medical devices, along with strategic opportunities through expanded manufacturing and distribution networks, which are anticipated to result in revenues of approximately $25 million for 2026. The acquisition is coupled with a $11 million brokered private placement of convertible debentures to fund the transaction, signaling growth strategies and enhanced operational capacity for the company.
More about LSL Pharma Group Inc
LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company focused on manufacturing consumer healthcare products. The company provides a variety of pharmaceutical and health-related products and serves major Canadian pharmacy banners and retail sectors, positioning itself within the growing Canadian Consumer Healthcare market.
Average Trading Volume: 62,354
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$42.43M
See more insights into LSL stock on TipRanks’ Stock Analysis page.